Selected Publications
Avraham Y., Bonne OB, Berry E.M., 1996.
Behavioral and neurochemical alterations caused by diet restriction - The effect
of tyrosine administration in mice. Brain Research 732,133-144.
Van Leeuwen, SD, Bonne OB, Avraham Y., 1997.
Separation as a new animal model for self induced weight loss. Physiology and
Behavior. 62,1,77-81.
Hao, S., Avraham, Y. Mechoulam, R. and Berry
E.M., 2000. Low dose anandamide affects food intake, cognitive function ,
neurotransmitter and corticosterone levels in diet-restricted mice. European
Journal of Pharmacology 392:147-156.
Hao S., AvrahamY., Bonne ,O. and Berry E.M.,.
2000. Separation –induced body weight loss impairment in alternation behaviour
and autonomic tone: effects of tyrosine. Pharmacology Biochemistry and Behavior
67, 1-9.
Avraham, Y., Hao S., Mendelson S. ,Bonne, O., and
Berry E.M. 2001., Diet restriction in mice causes a decrease in hippocampal
choline uptake and muscarinic receptors that is restored by administration of
tyrosine: interaction between cholinergic and adrenergic receptors influencing
cognitive function. Nutritional Neuroscience.4:153-167
Avraham Y., Hao, S., Mendelson, S., and E.M.
Berry., 2001. Tyrosine improves appetite , cognition and exercise tolerance in
activity anorexia. Medicine and Science in Sports and Exercise,33,
12:2104-2110
Avraham, Y., Hao S., Mendelson, S., and Berry,
E.M. 2002., Hypothalamic-Pituitary-Adrenal responses to weight loss in mice
following diet restriction, activity or separation stress :effects of tyrosine.
Nutritional Neuroscience, 5(5)327-335.
Shibolet,O., Alper R., , Avraham,Y., Berry,E.M.,
Ilan,Y., 2002. Immunemodulation of experimental colitis via caloric restriction
:role of NK1.1+T cells. Clinical Immunology 105(1) 48-56.
Hanus, L., Avraham Y, Ben Shushan,D., Zolotarev,
O., Berry, E.M., and Mechoulam, R., 2003. Short term fasting and prolong
semistarvation have opposite effects on 2-AG levels in mouse brain. Brain
Research 983, 144-151.
Gur, E., Newman, M., Avraham,Y., and Berry,E.M.,
2003 The effect of diet restriction on basal 5HT levels in hippocampus and
hypothalamus and the sensitivity of 5-HT1A and 5-HT1B. Nutritional Neuroscience.
6, 169-175.
Bonne O, Avraham Y, Katz M, Berry EM. 2003. Does
short-term diet restriction in mice precipitate the development of anorexia?
Nutritional Neuroscience 6, 197-199.
Avraham Y, Ben-Shushan D, Breuer A , Zolotarev O,
Okun A, Fink N, Katz V and Berry, E.M., 2004. Very low doses of delta-8 (THC)
increase food consumption and alter neurotransmitter levels following weight
loss. Pharmacology Biochemistry and Behaviour 77:675-684.
Avraham Y., Ben Menachem A., Okun A., Zolotarav
O., Abel N. ,Mechoulam R. and E. M. Berry., 2005. Effects of the endocannabinoid
noladin ether on body weight , food consumption, locomotor activity , and
cognitive index in mice. Brain Research Bulltin, 65:117-123.
Avraham Y, Israel E, Gabba E , Okun A, Zolotarev
O, Zilberman I, Ganzburg V, Dagon Y, Magen I, Vorobia L, Pappo O, Mechoulam, R,
Ilan Y and Berry, E.M., 2006. Endocannabinoids affect neurological and cognitive
function in thioacetamide-induced hepatic encephalopathy in mice. Neurobiology
of Disease 21, 237-245.
Dagon Y , Avraham Y, Magen I, Gertler A , Ben-Hur
T and Berry EM. 2005. Nutritional status, cognition and survival - a new role
for leptin and AMPK. J Biol Chem. 23; 280(51):42142-42148.
Dagon Y, Avraham Y and Berry EM., 2006. AMPK
activation regulates apoptosis, adipogenesis, and lipolysis by eIF2α in
adipocytes. BBRC 34043-34047.
Dagon Y, Avraham Y , Ilan Y, Mechoulam R and
Berry EM., 2007.Cannabinoids ameliorate cerebral dysfunction following liver
failure via AMP-activated protein kinase. FASEB J. 21(10): 2431-2441
Dagon Y, Avraham Y , Link G, Zolotarev O,
Mechoulam R and Berry EM., 2007. The synthetic cannabinoid HU-210 attenuates
neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12
cells.Neurobiol Dis. 2007 .27(2):174-81.
Avraham Y, Magen I, Zolotarev O, Vorobiav L,
Pappo O, Ilan Y, Elliot M. Berry EM and Ackerman Z.2-arachidonoylglycerol, an
endogenous cannabinoid receptor agonist, in various rat tissues during the
eveloution of experimental cholestatic liver disease . Prostaglandins Leukot
Essent Fatty Acids. 2008 79(1-2):35-40.
Avraham Y, Zolotarev O , Grigoriadis N,
Pautahidis T, Magen I, Vorobiav L, Zimmer A, Ilan Y,Mechoulam R, and Berry EM.
Cannabinoids and Capsaicin improve liver function following Thioacetamide
–induced acute injury in mice. American J Gastroentrol 2008
Dec;103(12):3047-56.
Iddo Magen, Yosefa Avraham, Zvi Ackerman, Olga
Zolotarev, Lia Vorobiev, Raphael Mechoulam and Elliot M. Berry. Cannabidiol
ameliorates cognitive and motor impairments in mice with cholestatic liver
disease. J of Hepatology 2009 51(3) 528-534.
Avraham Y, Grigoriadis N, Magen I, Pautahidis T,
Vorobiav L, Zolotarev O , Ilan Y,Mechoulam R, and Berry EM. Capsaicin affects
brain function in a model of hepatic encephalopathy associated with Fulminant
hepatic failure in mice British J of Pharmacology 2009 158,896-906.
Magen I ,Avraham Y, Ackerman Z, Vorobiav L,
Mechoulam R, and Berry EM. Cannabidiol ameliorates cognitive and motor
impairments in bile-duct ligated mice via 5-HT1A receptor activation. British J
of Pharmacology 2010 159:950-957.
Avraham Y, Davidi N, Porat M, Chernoguz D, Magen
I, Vorobeiv L, Berry EM, Leker RR. Leptin reduces infarct size in association
with enhanced expression of CB2, TRPV1, SIRT-1 and leptin receptor. Curr
Neurovasc Res 2010 7:136-143.
Avraham Y, Saidian M, Burston J J, Mevorach R,
Vorobiev L, Magen I, Kunkes K; Borges B; Lichtman,AH Berry EM. Fish oil promotes
survival and protects against cognitive decline in severely undernourished mice
by normalizing satiety signals.J Nutritional Biochemistry 2011
Aug;22(8):766-76.
Y Avraham, N C Grigoriadis, T Poutahidis, L
Vorobiev, I Magen, Y Ilan, R Mechoulam and Berry EM .Cannabidiol improves brain
and liver function in a Fulminant Hepatic Failure-induced model of hepatic
encephalopathy in mice British J of Pharmacology 2011 Apr;162(7):1650-8.
Borges BC, Rorato R, Avraham Y, da Silva LE,
Castro M, Vorobiav L, Berry EM, Antunes-Rodrigues J, Elias LL. LEPTIN RESISTANCE
AND DESENSITIZATION OF HYPOPHAGIA DURING PROLONGED INFLAMMATORY CHALLENGE. Am J
Physiol Endocrinol Metab. 2011 May;300(5):E858-69.
Avraham Y, Davidi N, Lassri V, Vorobiev L, Kabesa
M, Dayan M, Chernoguz D, Berry E, Leker RR. Leptin Induces Neuroprotection
Neurogenesis and Angiogenesis after Stroke. Curr Neurovasc Res. 2011
Nov;8(4):313-22.
Avraham Y, Amer J, Doron S, Abu-Tair L, Mahamid
M, Khatib A, Berry EM, Safadi R. The direct profibrotic and indirect immune
antifibrotic balance of blocking the cannabinoid 2 receptor. Am J Physiol
Gastrointest Liver Physiol. 2012 Jun 15;302(12):G1364-72.
Y. Avraham, M. Dayan, V. Lassri, L. Vorobiev, N.
Davidi, D. Chernoguz, E. Berry,1 and R.R. Leker.Delayed Leptin Administration
After Stroke Induces Neurogenesis and Angiogenesis. Journal of Neuroscience
Research, 2013 Feb;91(2):187-95
Avraham Y, Katzhendler J, Vorobeiv L, Merchavia
S, Listman C, Kunkes E, Harfuch F, Salameh S, Ezra AF, Grigoriadis NC, Berry EM,
Najajreh Y. Novel acylethanolamide derivatives that modulate body weight through
enhancement of hypothalamic Preopiomelanocortin (POMC) and/or decreased
Neuropeptide Y (NPY). J Med Chem. 14;56(5):1811-29.2013 Feb 5.
Reviews,commentaries, hypotheses,
editorialsAvraham Y, Dagon Y, Magen I and Berry E.M., 2005."Models of
Anorexia" Review in "Drug Discovery Today" ,Vol 2;3. Review.
Gabbay E., Avraham Y., Ilan Y., Israeli E C and
Berry EM., 2005. Endocannabinoids and Liver Disease, Review. Liver Int. Oct;
25(5):921-926.
Mechoulam R ,Berry EM, Avraham Y, Di Marzo V. and
Fride E. 2006.Endocannabinoids, feeding and suckling – a personal overview. in:
International J Obesity. Suppl 1:S24-8. 3.640;9/59 C;.Review.
Dagon Y, Avraham Y and Berry EM.2007 . Diet
restriction and the fruits of the tree of life. CellScience Reviews vol 4(2),
ISSN 1742-8130, 2007
Magen I ,Avraham Y, Berry E.M., and Mechoulam R
.Endocannabinoids in liver disease and hepatic encephalopathy. Curr Pharm Des.
2008; 14(23):2362-9. Review.
Avraham Y and Nachum S.Management of obesity in
menopause :Lifestyle modification,medication,bariatric surgery &personalized
treatment.Curr Topic in Menopause .2013 Chapter 7.
